1. Home
  2. FPF vs COLL Comparison

FPF vs COLL Comparison

Compare FPF & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Trust Intermediate Duration Preferred & Income Fund of Beneficial Interest

FPF

First Trust Intermediate Duration Preferred & Income Fund of Beneficial Interest

HOLD

Current Price

$18.53

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$48.63

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FPF
COLL
Founded
2013
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.5B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
FPF
COLL
Price
$18.53
$48.63
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$47.50
AVG Volume (30 Days)
186.7K
515.8K
Earning Date
01-01-0001
11-06-2025
Dividend Yield
8.08%
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.63
Revenue
N/A
$757,067,000.00
Revenue This Year
N/A
$26.35
Revenue Next Year
N/A
$3.67
P/E Ratio
N/A
$29.92
Revenue Growth
N/A
26.34
52 Week Low
$13.91
$23.23
52 Week High
$18.09
$49.16

Technical Indicators

Market Signals
Indicator
FPF
COLL
Relative Strength Index (RSI) 46.41 70.03
Support Level $18.45 $47.86
Resistance Level $18.57 $49.16
Average True Range (ATR) 0.13 1.29
MACD 0.01 -0.18
Stochastic Oscillator 49.94 88.24

Price Performance

Historical Comparison
FPF
COLL

About FPF First Trust Intermediate Duration Preferred & Income Fund of Beneficial Interest

First Trust Inter Dur Pref& Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek a high level of current income. Further, it has a secondary objective of capital appreciation. The Fund invests in the traditional preferred securities, hybrid preferred securities, floating rate & fixed-to-floating rate preferred securities, debt securities, convertible securities, and contingent convertible securities issued by U.S. and non-U.S. companies. Its investment portfolio includes industries such as Banks, Insurance, Capital Markets, Electric Utilities, Oil, Gas & Consumable Fuels, Food Products, and others.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: